RNA sequencing analysis of small cell lung cancer reveals candidate chemotherapy insensitivity long noncoding RNAs

Peng Kuang1, Peixin Chen2,3, Lei Wang2

  • 1Department of Medical Oncology, The First Affiliated Hospital Of Nanchang University, Nanchang 330006, China.

Abstract

Insights

This study identified key genes and microRNAs (miRNAs) that are downregulated in small cell lung cancer (SCLC) patients responding to chemotherapy. These findings may help predict treatment response and develop new strategies for SCLC chemotherapy insensitivity.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Gene expression profiling enhances understanding of lung cancer biology.
  • Small cell lung cancer (SCLC) treatment efficacy is a critical area of research.
  • Identifying molecular mechanisms of chemotherapy response in SCLC is essential.

Purpose of the Study:

  • To contrast transcriptomics profiling in SCLC patients with partial response (PR) versus stable/progressive disease (SD/PD) after first-line chemotherapy.
  • To investigate the roles of long noncoding RNAs (lncRNAs) and microRNAs (miRNAs) in SCLC chemotherapy efficacy.
  • To identify potential biomarkers for predicting SCLC treatment outcomes.

Main Methods:

  • RNA sequencing (RNA-Seq) was performed on tumor tissues from six SCLC patients.
  • Patients were categorized into PR and SD/PD groups based on their response to first-line chemotherapy.
  • Differential expression analysis was conducted for lncRNAs and miRNAs.

Main Results:

  • Significant differences in lncRNA and miRNA expression were observed between PR and SD/PD groups.
  • Three downregulated genes (HOXA-AS3, CASC9, KEGG) and two miRNAs (miRNA 601, miRNA 596) were identified in the PR group.
  • These identified genes and miRNAs may be associated with SCLC chemotherapy insensitivity.

Conclusions:

  • Downregulation of HOXA-AS3, CASC9, KEGG, miRNA 601, and miRNA 596 was noted in SCLC patients achieving PR.
  • These molecular markers show potential as predictive indicators for SCLC chemotherapy response.
  • Further research into these candidates could lead to improved therapeutic strategies for SCLC.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K